Exploring the Interplay between Cardiovascular Disease and Hormonal Changes during Menopause, With a Focus on Preventive Strategies

Menopause-i.e., the absence of menstruation for 12 months-usually happens between 45 and 55 years. The most important change is the reduction of estrogen, which plays a protective role for the cardiovascular system in the reproductive years. The depletion of estrogen introduces many changes like raised LDL cholesterol, arterial stiffness, metabolic disturbances, and altered susceptibility to causing or increasing incidences of hypertension, atherosclerosis, and, subsequently, stroke. Mixed methods were used to study 100 women aged 45 to 60 years under two conditions: with respect to being classified as premenopausal and postmenopausal and excluding women on hormone replacement therapy (HRT) and women with existing CVD. Quantitative data collection included cardiovascular assessments - blood pressure, lipid profiles, body composition - and hormonal assays (estradiol, progesterone). Validated questionnaires to capture menopausal symptoms, lifestyle habits, and mental health were used. Qualitative data were collected from in-depth interviews with 100 participants on their understanding of the risk of CVD and potential preventive mechanisms. Key results indicated that after menopause, the concentrations of estradiol diminished significantly, which was found to be linked to an increased risk for developing CVD, as confirmed by Chi-square test analysis. Preventive measures such as dietary modifications, physical exercise, and HRT were apparently a norm for most of the women, but some continued to be at risk, pointing to the need for targeted approaches. Women who complied with lifestyle changes had improved outcomes concerning cardiovascular health with quality of life (QoL). However, certain barriers prevailed like limited accessibility to health care and inadequate education, demonstrating the need for raising awareness and developing specific interventions